Hill-Rom Holdings Inc (HRC) 51.39 $HRC
Research Report Initiated on Select Healthcare Equities
ACCESSWIRE - Fri Jul 01, 8:16AM CDT
LONDON, UK / ACCESSWIRE / July 1, 2016 / Active Wall ST announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Healthcare industry. Companies recently under review include Quintiles Transnational, Bruker, StemCells, and Hill-Rom. See our complete report on Quintiles Transnational at:
Q: 71.37 (+0.55), STEM: 0.40 (+0.01), BRKR: 24.63 (+0.28), HRC: 51.39 (+0.35)
China Mobility Aids and Transportation Equipment Market Outlook to 2021 - Key Players are Stryker Corporation, Invacare Corporation, Hill-Rom Holdings - Research and Markets
BusinessWire - Tue Jun 28, 5:25AM CDT
Research and Markets has announced the addition of the "China Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 12.94 (-0.06), HRC: 51.39 (+0.35)
United States Mobility Aids and Transportation Equipment Market Outlook to 2021 - Key Players are Stryker, Invacare & Hill-Rom Holdings - Research and Markets
BusinessWire - Tue Jun 21, 12:13PM CDT
Research and Markets has announced the addition of the "United States Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 12.94 (-0.06), HRC: 51.39 (+0.35)
Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 115.60 (-0.14), LMAT: 13.82 (+0.18), NUVA: 61.42 (-0.15), HRC: 51.39 (+0.35)
Hill-Rom Holdings (HRC) Looks Good: Stock Adds 5.4% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:40AM CDT
Hill-Rom Holdings, Inc. (HRC) saw its shares rise almost 7% in the last trading session.
BAX: 46.65 (+0.16), HRC: 51.39 (+0.35)
Upgrade Alert for Hill-Rom Holdings (HRC)
Comtex SmarTrend(R) - Fri Jun 17, 3:05AM CDT
Hill-Rom Holdings (NYSE:HRC) was upgraded from Equal Weight to Overweight at Morgan Stanley today. The stock closed yesterday at $51.56 on volume of 1.3 million shares, above average daily volume of 540,000. Over the past year, Hill-Rom Holdings has traded in a range of $42.99 to $58.73 and closed yesterday at $51.55, 20% above that low. The 200-day and 50-day moving averages have moved 0.31% lower and 0.32% higher over the past week, respectively.
HRC: 51.39 (+0.35)
Hill-Rom: Welch-Allyn Buyout Drives Q2, Forex Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:20AM CDT
Hill-Rom (HRC) posted a mixed second quarter of fiscal 2016 with the bottom line surpassing the Zacks Consensus Estimate and the top line missing the same.
BSX: 23.81 (+0.04), BAX: 46.65 (+0.16), LMAT: 13.82 (+0.18), HRC: 51.39 (+0.35)
Hill-Rom to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Tue May 24, 9:00AM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, at 11:00 a.m. EDT.
HRC: 51.39 (+0.35)
Hill-Rom to Participate in the Goldman Sachs First Annual Leveraged Finance Conference
PR Newswire - Fri May 06, 1:30PM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs First Annual Leveraged Finance Conference on Tuesday, May 17, 2016, at 8:10 p.m. EDT.
HRC: 51.39 (+0.35)
Hill-Rom Declares Third Quarter 2016 Dividend
PR Newswire - Fri May 06, 8:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its Board of Directors declared a fiscal year 2016 third quarter dividend of $0.17 per share. This quarterly dividend represents a 6 percent increase over the amount paid a year ago. The dividend is payable on June 24, 2016, to shareholders of record as of the close of business on June 10, 2016.
HRC: 51.39 (+0.35)
Hill-Rom (HRC) Q2 Earnings Beat, Revenue Lag Estimates
Zacks Equity Research - Zacks Investment Research - Wed May 04, 8:05AM CDT
Hill-Rom (HRC) ended second-quarter fiscal 2016 on a mixed note with the bottom line surpassing the Zacks Consensus Estimate and top line missing the mark.
BSX: 23.81 (+0.04), SRDX: 24.52 (-0.27), BAX: 46.65 (+0.16), HRC: 51.39 (+0.35)
Hill-Rom to Participate in the Bank of America Merrill Lynch 2016 Health Care Conference
PR Newswire - Tue May 03, 12:00PM CDT
Hill-Rom Holdings, Inc. (NYSE:HRC) invites you to listen to a management presentation at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016, at 5:20 p.m. EDT.
HRC: 51.39 (+0.35)
Hill-Rom tops 2Q profit forecasts
Automated Insights - Fri Apr 29, 5:37AM CDT
CHICAGO (AP) _ Hill-Rom Holdings Inc. (HRC) on Friday reported fiscal second-quarter earnings of $22.3 million.
HRC: 51.39 (+0.35)
Hill-Rom Reports Higher Year-Over-Year Revenue And Adjusted Earnings And Updates Full Year Outlook
PR Newswire - Fri Apr 29, 5:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its second quarter ended March 31, 2016, and updated its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.71 represent an increase of 11 percent from $0.64 in the prior year, while reported earnings per diluted share decreased 27 percent from $0.45 to $0.33. Adjustments to reported earnings are detailed in the reconciliation schedules provided.
HRC: 51.39 (+0.35)
Hill-Rom to Participate in the Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Tue Apr 26, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) invites you to listen to a management presentation at the Deutsche Bank 41st Annual Health Care Conference on Wednesday, May 4, 2016, at 2:50 p.m. EDT.
DB: 14.09 (+0.79), HRC: 51.39 (+0.35)
Hill-Rom Holdings, Inc. Hosts Fiscal 2016 Second Quarter Earnings Conference Call and Webcast
PR Newswire - Fri Apr 01, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) will hold its fiscal 2016 second quarter earnings conference call and webcast on Friday, April 29, 2016, from 8:00 a.m. - 9:00 a.m. EDT.
HRC: 51.39 (+0.35)
Medtronic Unveils NURO System in US for Overactive Bladder
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:30PM CDT
We believe this product launch will allow Medtronic (MDT) to overcome the issues it has been facing in its Neuromodulation business division over the past couple of quarters
MDT: 88.59 (+0.08), OFIX: 47.07 (+0.09), HRC: 51.39 (+0.35), OSUR: 6.67 (+0.11)
Mead Johnson Launches Enfinitas Product Line in China
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:25PM CDT
Mead Johnson Nutrition Company (MJN) recently launched its Enfinitas premium-priced product line in China.
MJN: 90.13 (+0.36), BAX: 46.65 (+0.16), HRC: 51.39 (+0.35), OSUR: 6.67 (+0.11)
Quest Diagnostics Grows Through Organic, Inorganic Means
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:05PM CDT
On Mar 30, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
BAX: 46.65 (+0.16), DGX: 82.74 (-0.08), HRC: 51.39 (+0.35), OSUR: 6.67 (+0.11)
Cepheid Up on International Launch of Next-Gen MRSA Test
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 2:50PM CDT
Cepheid's (CPHD) Xpert MRSA NxG assay is a next-generation version of the market-leading molecular diagnostic test for Methicillin-Resistant Staphyloccus aureus (MRSA).
CPHD: 34.07 (+0.67), OFIX: 47.07 (+0.09), HRC: 51.39 (+0.35), OSUR: 6.67 (+0.11)
Research Report Initiated on Select Healthcare Equities
ACCESSWIRE - Fri Jul 01, 8:16AM CDT
LONDON, UK / ACCESSWIRE / July 1, 2016 / Active Wall ST announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Healthcare industry. Companies recently under review include Quintiles Transnational, Bruker, StemCells, and Hill-Rom. See our complete report on Quintiles Transnational at:
Q: 71.37 (+0.55), STEM: 0.40 (+0.01), BRKR: 24.63 (+0.28), HRC: 51.39 (+0.35)
China Mobility Aids and Transportation Equipment Market Outlook to 2021 - Key Players are Stryker Corporation, Invacare Corporation, Hill-Rom Holdings - Research and Markets
BusinessWire - Tue Jun 28, 5:25AM CDT
Research and Markets has announced the addition of the "China Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 12.94 (-0.06), HRC: 51.39 (+0.35)
United States Mobility Aids and Transportation Equipment Market Outlook to 2021 - Key Players are Stryker, Invacare & Hill-Rom Holdings - Research and Markets
BusinessWire - Tue Jun 21, 12:13PM CDT
Research and Markets has announced the addition of the "United States Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 12.94 (-0.06), HRC: 51.39 (+0.35)
Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 115.60 (-0.14), LMAT: 13.82 (+0.18), NUVA: 61.42 (-0.15), HRC: 51.39 (+0.35)
Hill-Rom Holdings (HRC) Looks Good: Stock Adds 5.4% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:40AM CDT
Hill-Rom Holdings, Inc. (HRC) saw its shares rise almost 7% in the last trading session.
BAX: 46.65 (+0.16), HRC: 51.39 (+0.35)
Upgrade Alert for Hill-Rom Holdings (HRC)
Comtex SmarTrend(R) - Fri Jun 17, 3:05AM CDT
Hill-Rom Holdings (NYSE:HRC) was upgraded from Equal Weight to Overweight at Morgan Stanley today. The stock closed yesterday at $51.56 on volume of 1.3 million shares, above average daily volume of 540,000. Over the past year, Hill-Rom Holdings has traded in a range of $42.99 to $58.73 and closed yesterday at $51.55, 20% above that low. The 200-day and 50-day moving averages have moved 0.31% lower and 0.32% higher over the past week, respectively.
HRC: 51.39 (+0.35)
Hill-Rom: Welch-Allyn Buyout Drives Q2, Forex Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:20AM CDT
Hill-Rom (HRC) posted a mixed second quarter of fiscal 2016 with the bottom line surpassing the Zacks Consensus Estimate and the top line missing the same.
BSX: 23.81 (+0.04), BAX: 46.65 (+0.16), LMAT: 13.82 (+0.18), HRC: 51.39 (+0.35)
Hill-Rom to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Tue May 24, 9:00AM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, at 11:00 a.m. EDT.
HRC: 51.39 (+0.35)
Hill-Rom to Participate in the Goldman Sachs First Annual Leveraged Finance Conference
PR Newswire - Fri May 06, 1:30PM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs First Annual Leveraged Finance Conference on Tuesday, May 17, 2016, at 8:10 p.m. EDT.
HRC: 51.39 (+0.35)
Hill-Rom Declares Third Quarter 2016 Dividend
PR Newswire - Fri May 06, 8:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its Board of Directors declared a fiscal year 2016 third quarter dividend of $0.17 per share. This quarterly dividend represents a 6 percent increase over the amount paid a year ago. The dividend is payable on June 24, 2016, to shareholders of record as of the close of business on June 10, 2016.
HRC: 51.39 (+0.35)
Hill-Rom (HRC) Q2 Earnings Beat, Revenue Lag Estimates
Zacks Equity Research - Zacks Investment Research - Wed May 04, 8:05AM CDT
Hill-Rom (HRC) ended second-quarter fiscal 2016 on a mixed note with the bottom line surpassing the Zacks Consensus Estimate and top line missing the mark.
BSX: 23.81 (+0.04), SRDX: 24.52 (-0.27), BAX: 46.65 (+0.16), HRC: 51.39 (+0.35)
Hill-Rom to Participate in the Bank of America Merrill Lynch 2016 Health Care Conference
PR Newswire - Tue May 03, 12:00PM CDT
Hill-Rom Holdings, Inc. (NYSE:HRC) invites you to listen to a management presentation at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016, at 5:20 p.m. EDT.
HRC: 51.39 (+0.35)
Hill-Rom tops 2Q profit forecasts
Automated Insights - Fri Apr 29, 5:37AM CDT
CHICAGO (AP) _ Hill-Rom Holdings Inc. (HRC) on Friday reported fiscal second-quarter earnings of $22.3 million.
HRC: 51.39 (+0.35)
Hill-Rom Reports Higher Year-Over-Year Revenue And Adjusted Earnings And Updates Full Year Outlook
PR Newswire - Fri Apr 29, 5:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its second quarter ended March 31, 2016, and updated its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.71 represent an increase of 11 percent from $0.64 in the prior year, while reported earnings per diluted share decreased 27 percent from $0.45 to $0.33. Adjustments to reported earnings are detailed in the reconciliation schedules provided.
HRC: 51.39 (+0.35)
Hill-Rom to Participate in the Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Tue Apr 26, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) invites you to listen to a management presentation at the Deutsche Bank 41st Annual Health Care Conference on Wednesday, May 4, 2016, at 2:50 p.m. EDT.
DB: 14.09 (+0.79), HRC: 51.39 (+0.35)
Hill-Rom Holdings, Inc. Hosts Fiscal 2016 Second Quarter Earnings Conference Call and Webcast
PR Newswire - Fri Apr 01, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) will hold its fiscal 2016 second quarter earnings conference call and webcast on Friday, April 29, 2016, from 8:00 a.m. - 9:00 a.m. EDT.
HRC: 51.39 (+0.35)
Medtronic Unveils NURO System in US for Overactive Bladder
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:30PM CDT
We believe this product launch will allow Medtronic (MDT) to overcome the issues it has been facing in its Neuromodulation business division over the past couple of quarters
MDT: 88.59 (+0.08), OFIX: 47.07 (+0.09), HRC: 51.39 (+0.35), OSUR: 6.67 (+0.11)
Mead Johnson Launches Enfinitas Product Line in China
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:25PM CDT
Mead Johnson Nutrition Company (MJN) recently launched its Enfinitas premium-priced product line in China.
MJN: 90.13 (+0.36), BAX: 46.65 (+0.16), HRC: 51.39 (+0.35), OSUR: 6.67 (+0.11)
Quest Diagnostics Grows Through Organic, Inorganic Means
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:05PM CDT
On Mar 30, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
BAX: 46.65 (+0.16), DGX: 82.74 (-0.08), HRC: 51.39 (+0.35), OSUR: 6.67 (+0.11)
Cepheid Up on International Launch of Next-Gen MRSA Test
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 2:50PM CDT
Cepheid's (CPHD) Xpert MRSA NxG assay is a next-generation version of the market-leading molecular diagnostic test for Methicillin-Resistant Staphyloccus aureus (MRSA).
CPHD: 34.07 (+0.67), OFIX: 47.07 (+0.09), HRC: 51.39 (+0.35), OSUR: 6.67 (+0.11)
